BioReports - table of contents

BioReports
Table of Contents

Database Interface

Results -- View
BioReports - table of contents
Biotechnology, Pharmaceutical and Life Science Reports
Biotechnology, Pharmaceutical and Life Science Reports
Evolution Life Science Front Line Strategic Consulting Growthink
Biotech Learning Institute Learning Courses
BioInformatics - Life Science Products,Synthetic Oligonucleotides, RNA Interference Products, RNA Purification, SNP Genotyping, DNA Microarrays, Protein Microarrays, autoimmune Disease Research
Kalorama - The Worldwide Market for Prescription Dermatological Drugs, Monoclonal Antibodies in Cancer Therapy Emerging Products and Markets, Worldwide Market for Cancer Therapeutics, Autism Therapeutics - A Market Briefing, The World Market for Anti-Infectives, Volume II - Antibacterials, Direct-to-Consumer Pharmaceutical Marketing 2005 - Controversies Continue, Hispanics and Healthcare - Understanding Demographics, Health Statistics, and Attitudes for More Effective Marketing, Worldwide Market for Prescription Cardiovascular Drugs, Cardiovascular Disease The 45+ Market in the United States for Drugs and Medical Devices, Schizophrenia Therapeutics - A Market Briefing, The U.S. Market for Interventional Radiology Products, World Market for Anti-Infectives, Volume I - Antifungals, Diabetes and Diabetic Complications - Major World Markets, 2nd Edition, U.S. Market for Molecular Diagnostics, 2nd Edition, Neurological Catheters - A Market Briefing, Computer-Assisted Surgical Systems: A Market Briefing, Inhaled Insulin A Market Briefing, Type II Diabetes The 45+ Market in the United States for Drugs and Diagnostics
Business Insights - The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players, Beyond the Blockbuster Drug: Strategies for nichebuster drugs, targeted therapies and personalized medicine, The Pharmaceutical Market Outlook to 2015 - Implementing innovative, long-term strategies for sustainable future growth, Pharmaceutical Project and Portfolio Management - Effective organization and decision-making for long-term growth, Drug Safety in the Post-Vioxx Era - New legislation, regulation and company strategies in Europe and the US, Pharmaceutical Pricing Strategies: Price optimization, reimbursement and regulation in Europe, US and Japan, Emerging Drug Discovery Technologies: Building competitive advantage through lab-on-a-chip, nanotechnology and RNAi, The Top 10 Biotechnology Companies The Cardiovascular Market Outlook to 2010, Lead Optimization Strategies: Future developments, threats and opportunities for big pharma, specialty pharma and biotech, Pharmaceutical Anti-Counterfeiting Strategies: Protecting profits through operational security, new technologies and industry partnerships, Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies
Datamonitor Respiratory Reports - Rigel's Allergic Rhinitis Candidate - R112, Respiratory Handbook 2005-15 - Novartis Moving Into the Major League, Asthma - Combination Therapy Appropriate for Everyone, Asthma, COPD, Allergic Rhinitis - As Patents Expire, Novel Combinations Inspire, Respiratory Key Players - GSK Blows Away the Opposition, Asthma and COPD - Control is the Goal, Allergic Rhinitis - Is There Life After Claritin, Asthma, COPD and Allergic , Rhinitis - Weak Late Stage Pipeline Leaves Innovation to Phase I/II Candidates, Respiratory Syncytial Virus: Can Antivirals Make the Grade, Community Acquired Respiratory Tract Infections - Room for Ketek
Arrowhead Publishers - Biogenerics, Amgen - Profile, Autoimmune/Inflammatory Disease, Pain Therapeutics, Cancer Vaccines, Prescription Generic Markets, Monoclonal Antibody, PHARMACEUTICAL R&D, Biotech Alliances, CRO Outsourcing
AS Insights Opportunity and Valuation Reports - Colony Stimulating Factors, Interferon, Erythropoietin, Monoclonal Antibody, Aromatase Inhibitors in Breast Cance, Vascular Targeting Agents, Biopharmaceuticals, Drug Eluting Stents Technology, Carotid Stents Technology, Neuro Stents & Coils Technology
TriMark Publications - Multi-Parameter Patient Monitor Markets: Trends, Industry Participants, Product Overview, and Market Drivers, Key Diagnostic Testing Markets, Women’s Health: Diagnostic Tests, Disposable Medical Supplies, High-Growth Diagnostics Tests Markets, Cardiac Rhythm Management Device World Markets: Defibrillators, Pacemakers and Leads, Cancer Therapeutics Markets, Disposable Syringes Markets, Point Of Care Diagnostic Testing World Markets, Bioin ormatics State of the Art ,Clinical Chemistry Analyzers Veterinary Health Markets, Mammography World Markets, Diabetes, Metabolic Syndrome & Cardiovascular Disease: Reshaping Tomorrow's Diabetes Market, Cancer Diagnostic Testing World Market, Microscopy Markets , Molecular Diagnostics Markets, Cardiac Marker Diagnostic Tests Markets, DNA Sequencing and PCR markets Blood Gas Instrumentation Data Processing, Genomics World Markets , Over The Counter Diagnostic Product World Markets
CuttingEdgeInfo - Accelerating Clinical Trials: Budgets, Patient Recruitment & Productivity, Cardiovascular Marketing: Budgets, Staffing and Strategy, Pharmaceutical Patient Compliance and Disease Management, Oncology Brand Commercialization: Resource Allocation (PH68) , Pharmaceutical Medical Publications: Winning Physician Support (PH67) , European Pharmaceutical Marketing: Launching Successful Brands (PH71), Pharmaceutical Sales: Driving Access and Influencing Prescribers (PH65) , Next-Generation MSL Programs: Performance Metrics and Value (PH75), Defending Brand Revenue: Pharmaceutical Lifecycle Management Planning (PH69) , Pharmaceutical Sales: Driving Access and Influencing Prescribers (PH65) , Business Development Spending and Structure: Priming the Pharmaceutical Pipeline (PH70) , Pharmaceutical Market Research (PH63), Pharmaceutical Thought Leaders: Brand Strategies and Product Positioning, Pharmaceutical Product Commercialization:Phase III to Post-Launch Resource Allocation, Pharmaceutical Competitive Intelligence: Building Strategic Advantage (PH66) , Combating Generics: Pharmaceutical Brand Defense Pharmaceutical Product Commercialization: Pre-Clinical to Phase III Resource Allocation
Jain PharmaBiotech - Nitric Oxide - Therapeutics, Markets and Companies, Personalized Medicine - scientific & commercial aspects, Pain Therapeutics - Drugs, Markets and Companies, Drug Delivery in Cancer - technologies, markets and companies, Molecular Diagnostics - Technologies, Markets and Companies, RNAi - technologies, markets and companies, Alzheimer disease - new drugs, markets and companies, Cell Therapy - Technologies, Markets and Companies, Animal Biotechnology - Technologies, Markets and Companies, Nanobiotechnologies- applications, markets and companies, Drug Delivery in Central Nervous System Disorders - technologies, markets and companies, Transdermal Drug Delivery - Technologies, Markets, and Companies, Cardiovascular Drug Delivery - technologies, markets and companies, Neuroprotection - Drugs, Markets and Companies roteomics - Technologies, Markets and Companies, Gene Therapy - technologies, markets and companies
Visiongain - Top 10 Biotech Companies 2004: Innovators and Leaders in the Market, Blockbuster Drugs: A Current Assessment and Outlook for Creating Future Blockbusters, The Cardiovascular Report, Pharmaceutical Packaging and Labeling: New Techniques and Market Trends, Orphan Drugs: Future Directions for a High Growth Market 2004-2009, The Global Ophthalmic Pharmaceutical Market 2004-2009, In Vitro Diagnostics in the Global Market, The World Pharmaceutical Wholesale and Distribution Industry 2005, Collaborations and Licensing in Global Pharmaceuticals and Biotech, The World Biotech Market 2005, Pricing and Reimbursement 2005 - 2006, Evaluating Key Strategic Issues, Biotech Israel, Controlled Release: The Future of Drug Delivery, Venture Capital Investment in Biotech, The Global Veterinary Pharmaceutical Market, World Neurodegeneratives Disease Markets, 2005-2009, The World Market for Anti-Fungal Therapies, The Global Endocrine Pharmaceutical Market 2005, Anticonvulsants 2005, Therapeutic Proteins, Cannabinoids: A potential blockbuster, Pharmacoeconomics tatins and the AntiCholesterol Market 2004-2009, Antisense Therapies 2004: Commercialization and Research Trends, Modern Drug Discovery Markets, 2004-2009 Angiogenesis Inhibitors and Stimulators: The Emergence of a New Market The Pain Report 2004 ,The World Erectile Dysfunction Markets, 2004-2009, Urinary Track Agents Annual Report 2005, Cancer Therapies 2004: New Market Dynamics and Products
Urch Publishing - Orphan Drugs to 2008, Research & Development in the Pharmaceutical Industry Generic Competition to 2009 - The impact of patent expiries on sales of major drugs, Health Economics in the Drug Life Cycle, Opportunities in Drug Delivery Identifying hot technologies, companies and markets, European Pharmaceutical Regulation, Pharmaceutical Pricing Global Perspectives, Pricing & Reimbursement of Medicines in the United Kingdom, Global Pharmaceutical Fine Chemicals
LeadDiscovery - Asthma Therapeutics: New treatment options and emerging drug discovery targets, 5-HT7 antagonists: Novel molecules for the unmet migraine prophylaxis market, Rheumatoid arthritis: Emerging drug discovery targets and therapeutic candidates, Aurora Kinase inhibitors - The dawn of a new approach to cancer, The retinoids : Therapeutic & pharmaceutical opportunities, Histone deacetylase inhibitors: Moving from the bench to a promising companion for classic and targeted cancer therapies, COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact , Developments in oncolytic viruses - An emerging approach to cancer therapeutics
Walnut Medical
Cambridge Healthtech Advisors - Successful Outsourcing of Pharmaceutical R&D: Trends and Strategies Metabolic Syndrome: Pipeline Analysis and U.S. Market Forecast, Inflammatory Disease Therapeutics: Pipelines and Competitive Dynamics , 2015: Strategic Considerations for the U.S. Pharmaceutical Industry, Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches, Toxicogenomics and Predictive Toxicology: Market and Business Outlook, Model Animal Systems Emerging Applications and Commercial Opportunities in Drug Discovery and Development, Hematological Cancer Therapeutics - Pipelines and Competition, Cardiovascular Diagnostics - Key Developments in Technologies and Markets, Biomarkers in Clinical Development: Implications for Personalized Medicine and Streamlining R&D, Pharmaceutical R&D Productivity - The Path to Innovation Microarrays: Technologies, Applications, Markets, Clinical Genomics Molecular Imaging Comes of Age - Applications and Impacts in Discovery, Clinical Trials, and Medical Practice, Powering Discovery through Target Evaluation - Moving Beyond the Validation Paradigm, High-Content Analysis Market Outlook, Proteins: Selection, Synthesis, and Purification Strategies for Optimizing Drug Discovery, New Directions in Monoclonal Antibodies: Technologies, Markets, Competition, Pharmacodiagnostics - Technologies, Competition, and Market Models Nutrigenomics - Impacts on Markets, Diets, and Health, Chronic Obstructive Pulmonary Disease (COPD) Therapeutics
Drug and Market Development - Post-Genomic Biomarkers, Drug Development, G-Protein Coupled Receptors (GPCRs)
Drug and Market Development Guides - A Guide to Due Diligence in Life Science Transactions, Green-Fluorescent Protein Evaluating and Choosing CROs, Successful Pharmaceutical Patent Writing Good Facility Design Practice, Viral Clearance, Pharmacovigilance in the EU Good Clinical Practice - 2nd Edition , Good Laboratory Practice: For Start-up and Growing Laboratories in Industry and Academia 2004, Business Plan Writing, 2nd edition, Successful Technology Licensing, Raising Capital, Fixation and Preservation of Tissues, HTS Assay Development, Achieving Reimbursement for Medical Devices, Diagnostics, and Pharmaceuticals, Competitive Intelligence for the Life Sciences Industry, Building and Managing Successful Strategic Alliances, Good Validation Practice, Good Manufacturing Practice, Pharmaceuticals in the European Union (EU) - The Impact of EU Enlargement, Successful SBIR STTR Grant Writing, Good Clinical Practice, European Union Pharmaceutical Regulations
Results -- View
Results -- View
Biotechnology, Pharmaceutical and Life Science Reports
Select Bioscience - Molecular Diagnostics 2005, Protein BioChips: Parallelized screening for high-output biology, Secondary Screening , RNAi - technologies, markets and companies, Cell Culture Products: European Customer Market Survey, Proteomics, Tissue Microarrays Directory of Molecular Diversity Suppliers, Protein Crystallography, Molecular Biology Products: European Market Survey
Arachnova Technology Web

BioPortfolio's BioReports catalogue is one of the most comprehensive sources of specialized life science management reports on the internet. You can search our database by using the links below:

If you represent a publisher who wishes to market via BioPortfolio's BioReports service please contact Peter Barfoot.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright © 1997-2008 - BioPortfolio Limited.